arrow_back Civic Audit
Share share

PFAS Accountability: New Rights for Exposed Individuals and Medical Monitoring

This act introduces new rights for individuals exposed to harmful PFAS substances, allowing them to pursue claims in federal court. Citizens can seek coverage for medical examinations to detect PFAS-related diseases, with the responsibility for these costs falling on manufacturers. This aims to encourage companies to prioritize chemical safety.
Key points
Individuals exposed to PFAS can sue manufacturers in federal courts for damages.
The act allows for funding of medical examinations (medical monitoring) to detect PFAS-related diseases early.
Companies responsible for PFAS production or use may bear the costs of medical monitoring, encouraging research into the safety of these substances.
The act does not limit the ability to pursue claims under state law.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 118_HR_7194
Sponsor: Rep. Dean, Madeleine [D-PA-4]
Process start date: 2024-02-01
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

PFAS Accountability Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_7194.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-02-01.

What are the main provisions?

Key points include:

  • Individuals exposed to PFAS can sue manufacturers in federal courts for damages.
  • The act allows for funding of medical examinations (medical monitoring) to detect PFAS-related diseases early.
  • Companies responsible for PFAS production or use may bear the costs of medical monitoring, encouraging research into the safety of these substances.
  • The act does not limit the ability to pursue claims under state law.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Dean, Madeleine [D-PA-4].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Environment, Manufacturing, and Critical Materials.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Courts and Law Environment